Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

SRR6013514

· cohortMD2

0778e8ab-a069-5303-bee8-24ef093ae8ff

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
cohortMD2
subtype
cohortMD2

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: Request returned HTTP 429 for HTTP HEAD to 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/lung-landscapes/6/gsva.parquet' LINE 1: SELECT pathway_library_id, pathway_name, gsva_score FROM read_parquet('https://pub-e056b053afc04eec88337b62541f3025... ^

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1X038167c2.c7d9.47a2.9172.1cfe391c8131
lung-landscapes@6
cohortMD20.944
2MBCProject_1819_T2A_RNA
breast-umap@18
A0.938
3TCGA-77-A5FZ-01A-31R-A27Q-07
lung-landscapes@6
cohortMD20.923
4TCGA-AN-A0FN-01A-11R-A034-07
breast-umap@18
A0.917
5f22cfa82-a346-4fed-bc81-21a29bf990ee
colon-landscapes@1
0.911
6C3N-02923
lung-landscapes@6
cohortMD20.911
7c277dab0-361f-4aa6-96b1-522a6e556ae1
colon-landscapes@1
0.909
8TCGA-XF-AAME-01A-12R-A42T-07
bladder-landscape@3
0.906
9ec054d40-e5b8-496a-8c99-5e7f88f2cf37
colon-landscapes@1
0.905
102cec663c-00c8-48b5-967b-f2a53c0fb409
colon-landscapes@1
0.903

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 26 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
ALLOGRAFT_REJECTION0.560Idelalisib— uncovered
EPITHELIAL_MESENCHYMAL_TRANSITION0.560Inavolisib— uncovered
COMPLEMENT0.490Inavolisib— uncovered
ANGIOGENESIS0.470Remibrutinib— uncovered
IL6_JAK_STAT3_SIGNALING0.450Inavolisib— uncovered
INFLAMMATORY_RESPONSE0.450Idelalisib— uncovered
TNFA_SIGNALING_VIA_NFKB0.450Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.410Idelalisib— uncovered
IL2_STAT5_SIGNALING0.370Idelalisib— uncovered
COAGULATION0.340Binimetinib— uncovered
KRAS_SIGNALING_UP0.320Inavolisib— uncovered
MYOGENESIS0.320Inavolisib— uncovered
UV_RESPONSE_DN0.320Inavolisib— uncovered
HYPOXIA0.310Idelalisib— uncovered
APOPTOSIS0.280Idelalisib— uncovered
PANCREAS_BETA_CELLS0.260Cobimetinib— uncovered
TGF_BETA_SIGNALING0.210Inavolisib— uncovered
APICAL_SURFACE0.170Temsirolimus— uncovered
APICAL_JUNCTION0.150Inavolisib— uncovered
INTERFERON_ALPHA_RESPONSE0.130Inavolisib— uncovered